Stryker Orthopaedics and Spine — Foreign exchange and other remained flat by 0.0% to -$42.50M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 707.1%, from $7.00M to -$42.50M. Over 3 years (FY 2021 to FY 2024), Orthopaedics and Spine — Foreign exchange and other shows a downward trend with a 9.6% CAGR.
Positive values indicate a tailwind from currency or other factors, while negative values indicate a headwind that masks or detracts from operational performance.
Captures the impact of currency fluctuations and miscellaneous non-operating factors on the Orthopaedics segment's finan...
Comparable to 'foreign currency impact' or 'FX translation effects' reported by multinational healthcare companies.
syk_segment_orthopaedics_foreign_exchange_and_other| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | -$129.00M | -$88.00M | $28.00M | -$170.00M |
| YoY Change | — | +31.8% | +131.8% | -707.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.